Dextran sulfate-based MMP-2 enzyme-sensitive SR-A receptor targeting nanomicelles for the treatment of rheumatoid arthritis

Yu, Caiwei; Liu, Hui; Guo, Caixia; Chen, Qiang; Su, Yanguo; Guo, Huimin; Hou, Xiaoya; Zhao, Feng; Fan, Hui; Xu, Hui; Zhao, Yaxian; Mu, Xiaofeng; Wang, Guohua; Xu, Haiyu; Chen, Daquan

doi:10.1080/10717544.2022.2032482

Cited by 36 publications

(32 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The EE of drugs was calculated as EE%=( W encapsulated / W total )×100%, where W encapsulated and W total represent the amount of drugs in the liposomes and the total amount of drugs, respectively. The drug loading (DL%) of liposomes was calculated using the following equation: DL%=( W loaded drug / W Total amount of lipids )×100% (Yu et al., 2022 ). Ang2-ICA/TSIIA liposomes were stored at 4 °C, and the particle size, EE%, and leakage rate (LR) were investigated at 0, 10, 20, and 30 days, respectively.…”

Section: Methodsmentioning

confidence: 99%

Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer’s disease

et al. 2022

View full text Add to dashboard Cite

The blood–brain barrier (BBB) is a protective barrier for brain safety, but it is also a major obstacle to the delivery of drugs to the cerebral parenchyma such as the hippocampus, hindering the treatment of central nervous system diseases such as Alzheimer’s disease (AD). In this work, an anti-AD brain-targeted nanodrug delivery system by co-loading icariin (ICA) and tanshinone IIA (TSIIA) into Aniopep-2-modified long-circulating (Ang2-ICA/TSIIA) liposomes was developed. Low-density lipoprotein receptor-related protein-1 (LRP1) was a receptor overexpressed on the BBB. Angiopep-2, a specific ligand of LRP1, exhibited a high binding efficiency with LRP1. Additionally, ICA and TSIIA, drugs with neuroprotective effects are loaded into the liposomes, so that the liposomes not only have an effective BBB penetration effect, but also have a potential anti-AD effect. The prepared Ang2-ICA/TSIIA liposomes appeared narrow dispersity and good stability with a diameter of 110 nm, and a round morphology. Cell uptake observations, BBB models in vitro , and imaging analysis in vivo showed that Ang2-ICA/TSIIA liposomes not only penetrate the BBB through endocytosis, but also accumulate in N2a cells or brain tissue. The pharmacodynamic analysis in vivo demonstrated that Ang2-ICA/TSIIA liposomes could improve AD-like pathological features in APP/PS1 mice, including inhibiting neuroinflammation and oxidative stress, reducing apoptosis, protecting neurons, and improving cognitive function. Therefore, Ang2-ICA/TSIIA liposomes are considered a potentially effective therapeutic strategy for AD.

show abstract

Section: Methodsmentioning

confidence: 99%

Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer’s disease

et al. 2022

View full text Add to dashboard Cite

show abstract

“…PVGLIG (0.1 mmol) was added to the above mixture under stirring and continuously stirred for 36 h (37 °C). Subsequent methods similarly added DS to obtain DPC (Figure A) . We guess that MMP-2 enzyme was used to cut off PVGLIG; this will release and produce Cel in inflammatory sites of highly expressed MMP-2 enzyme.…”

Section: Methodsmentioning

confidence: 99%

“…Liu et al reported that it could enhance leptin sensitivity for weight-loss studies. ,− So, celastrol has emerged as a promising drug candidate for the treatment of obesity. ,,− We found that one of the members of the zinc-dependent endopeptidase group is matrix metalloproteinase (MMP). Increasing studies have shown that MMP-2 enzyme is excessively secreted in inflammation. − Du et al reported the use of MMP-2-enzyme-sensitive (PVGLIG peptide) nanoparticles for acute kidney injury . Yu et al reported the use of MMP-2-enzyme-sensitive nanoparticles for rheumatoid arthritis .…”

Section: Introductionmentioning

confidence: 99%

“…Increasing studies have shown that MMP-2 enzyme is excessively secreted in inflammation. − Du et al reported the use of MMP-2-enzyme-sensitive (PVGLIG peptide) nanoparticles for acute kidney injury . Yu et al reported the use of MMP-2-enzyme-sensitive nanoparticles for rheumatoid arthritis . So, MMP-2-sensitive nanoparticles allow for the precise release of inflammation.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Celestrol-Loaded Nanoscale Micelles Derived from Dextran Sulfate/PVGLIG/Celestrol with MMP-2 Sensitivity for the Treatment of High-Fat-Diet-Induced Obesity

Chen

Guo

et al. 2022

ACS Appl. Nano Mater.

Self Cite

View full text Add to dashboard Cite

With the improvement of people’s living standards, obesity has become a health threat, but an effective drug treatment for obesity has not been found yet. Here, we suggest the use of celastrol, a pentacyclic triterpenoid from the traditional Chinese medicine Tripterygium wilfordii, which has a powerful antiobesity effect. Increasing studies have discovered that obesity is closely related to inflammation. In addition, MMP-2 enzyme is highly expressed in inflammatory sites. According to the principle of the prodrug, celastrol was used as a hydrophobic group, PVGLIG as a link, and dextran sulfate as a hydrophilic group to form a micelle (DS-PVGLIG-Cel). Celastrol was then loaded for the effective treatment of high-fat-diet (HFD)-induced obesity. MMP-2-sensitive assays confirmed that PVGLIG cleavage by MMP-2 enzymes favors the synchronous release of celastrol. A series of animal experiments tested that the preparation group has a strong weight loss effect. Our results suggest that this will shed light on a strategy for the subsequent effective treatment of HFD obesity.

show abstract

“…The development of OA and RA is associated with the increased secretion and activity of MMP-2 in synovial cells and the joints of RA patients, respectively ( Kim et al, 2011 ; Galasso et al, 2012 ). Furthermore, MMP-2-sensitive peptide was shown to be specifically released in inflammatory joints in vitro and in vivo , which might be an important approach for drug-targeted treatment of RA ( Yu et al, 2022 ).…”

Section: Introductionmentioning

confidence: 99%

Recent advances in enzyme-related biomaterials for arthritis treatment

et al. 2022

View full text Add to dashboard Cite

Arthritis is a group of highly prevalent joint disorders, and osteoarthritis (OA) and rheumatoid arthritis are the two most common types. The high prevalence of arthritis causes severe burdens on individuals, society and the economy. Currently, the primary treatment of arthritis is to relieve symptoms, but the development of arthritis cannot be effectively prevented. Studies have revealed that the disrupted balance of enzymes determines the pathological changes in arthritis. In particular, the increased levels of matrix metalloproteinases and the decreased expression of endogenous antioxidant enzymes promote the progression of arthritis. New therapeutic strategies have been developed based on the expression characteristics of these enzymes. Biomaterials have been designed that are responsive when the destructive enzymes MMPs are increased or have the activities of the antioxidant enzymes that play a protective role in arthritis. Here, we summarize recent studies on biomaterials associated with MMPs and antioxidant enzymes involved in the pathological process of arthritis. These enzyme-related biomaterials have been shown to be beneficial for arthritis treatment, but there are still some problems that need to be solved to improve efficacy, especially penetrating the deeper layer of articular cartilage and targeting osteoclasts in subchondral bone. In conclusion, enzyme-related nano-therapy is challenging and promising for arthritis treatment.

show abstract

Dextran sulfate-based MMP-2 enzyme-sensitive SR-A receptor targeting nanomicelles for the treatment of rheumatoid arthritis

Cited by 36 publications

References 28 publications

Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer’s disease

Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer’s disease

Celestrol-Loaded Nanoscale Micelles Derived from Dextran Sulfate/PVGLIG/Celestrol with MMP-2 Sensitivity for the Treatment of High-Fat-Diet-Induced Obesity

Recent advances in enzyme-related biomaterials for arthritis treatment

Contact Info

Product

Resources

About